Partner
Capricorn PartnersCheck size: Capricorn Partners manages multiple specialist funds; check sizes vary by strategy. Its Healthtech Fund II publishes €1M-€5M investments.
Rob van der Meij invests through Capricorn Partners's published strategy: Invest across specialist European technology strategies where deep technical expertise can support companies in health, digital, chemistry, industrial biotechnology, cleantech and related fields.
Innovative European companies with technology as a competitive advantage, strong management and the potential for strategic and financial impact.
Companies without meaningful technology differentiation, European relevance or fit with a specialist Capricorn fund are less aligned.
Match the company to the relevant specialist fund and show the technology moat, validation, market, management team, capital plan and measurable impact.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Rob van der Meij is listed by Capricorn Partners as Partner on the firm's current official roster. No employment history or personal investment preferences are inferred beyond the official title and firm-level strategy.